Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium
Featuring perspectives from Dr Terence Friedlander, Dr Matthew
Galsky, Dr Shilpa Gupta and Prof Andrea Necchi, moderated by Dr
Friedlander, including the following topics:
Case: A patient with T4 disease, pelvic wall involvement and a
positive pelvic node treated as metastatic disease with enfortumab
vedotin and pembrolizumab attains a complete response on imaging
after 6 cycles (0:00)
Case: A man with muscle-invasive bladder cancer who receives
neoadjuvant chemotherapy with durvalumab receives positive
circulating tumor DNA results before cystectomy and negative
results after surgery (7:41)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.